Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             54 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A Clinical Nomogram for Predicting Overall Survival in Patients With T1/T2 Penile Squamous Cell Carcinoma Qian, Shian

22 5 p.
artikel
2 A Comparison of ChatGPT and Human Questionnaire Evaluations of the Urological Cancer Videos Most Watched on YouTube Demirci, Aykut

22 5 p.
artikel
3 A Real World Observational Study Characterizing Patients With Advanced Prostate Cancer Treated With or Without Androgen Receptor-Pathway-Inhibitor Therapies in Alberta, Canada O'Sullivan, Dylan E.

22 5 p.
artikel
4 Assessing the Heterogeneity of Response of [68Ga] Ga-PSMA-11 PET/CT Lesions in Patients With Biochemical Recurrence of Prostate Cancer Dell'Oro, Mikaela

22 5 p.
artikel
5 A Systematic Review of Clinical Trials Comparing Radiation Therapy Versus Radical Prostatectomy in Prostate Cancer Hekman, Lauren

22 5 p.
artikel
6 Bi-Parameter MRI Could Quantitatively Assess the Zonal Heterogeneity of Prostate Cancer Han, Ye

22 5 p.
artikel
7 Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A1*28 Polymorphism Mobaraki, Sajedeh

22 5 p.
artikel
8 Can Bladder MRI Improve the Follow-Up of Non–Muscle-Invasive Bladder Cancer by Detecting Endoscopic Invisible Recurrence? Dewulf, Karel

22 5 p.
artikel
9 Clinical Outcomes and Risk Stratification in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With New-Generation Androgen Receptor Signaling Inhibitors Suzuki, Kotaro

22 5 p.
artikel
10 Combination Chemotherapy With TS-1 and Cisplatin for Urinary Adenocarcinoma: A Retrospective Case Series Omiya, Akifumi

22 5 p.
artikel
11 Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) Registry Cortes, Julian A.

22 5 p.
artikel
12 Comment on “An Update on Focal Therapy for Prostate Cancer” Sudhakaran, Gokul

22 5 p.
artikel
13 Comment on “Evaluating Biomarkers for Testosterone Replacement Efficacy in Testicular Cancer Survivors With Mild Leydig Cell Insufficiency” Sudhakaran, Gokul

22 5 p.
artikel
14 Comment on Real-world Efficacy and Toxicity Analysis of Abiraterone Acetate versus Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer in Asian Patients Sudhakaran, Gokul

22 5 p.
artikel
15 Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer Del Re, Marzia

22 5 p.
artikel
16 Disparities in Penile Cancer Incidence, Mortality, and Place of Death Trends From 1999 to 2020 Mansur, Arian

22 5 p.
artikel
17 Disulfidptosis-Related LncRNA Signatures for Prognostic Prediction in Kidney Renal Clear Cell Carcinoma Jeyaraj, Gnanaprakash

22 5 p.
artikel
18 Dual mTOR1/2 Inhibitor Sapanisertib (FTH-003/TAK-228) in Combination With Weekly Paclitaxel in Patients With Previously Treated Metastatic Urothelial Carcinoma: A Phase II Open-Label Study Bellmunt, Joaquim

22 5 p.
artikel
19 Effect of Bacillus Calmette–Guerin Exposure on Prostate Cancer Detection Using Magnetic Resonance Imaging: A Cohort Study Rodríguez Cabello, Miguel Angel

22 5 p.
artikel
20 Effect of Treatment of Residual Disease After Immunotherapy-Based Combinations on Complete Response Rate of Patients With Metastatic Renal Cell Carcinomas Moinard-Butot, F.

22 5 p.
artikel
21 Final Analysis of a Noninterventional Study on Cabozantinib in Patients With Advanced Renal Cell Carcinoma After Prior Checkpoint Inhibitor Therapy of the German Interdisciplinary Working Group on Renal Tumors (IAG-N) Viktor, Grünwald

22 5 p.
artikel
22 Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives Turco, Fabio

22 5 p.
artikel
23 Immune-Related Adverse Events Can Predict Progression-Free and Overall Survival In Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors Silberg, Matteo

22 5 p.
artikel
24 Immunotherapy Plus Chemotherapy Versus Chemotherapy Alone as First-Line Treatment for Advanced Urothelial Cancer: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials Mamede, Isadora

22 5 p.
artikel
25 Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer Skelton IV, William Paul

22 5 p.
artikel
26 Impact of DPP4 Inhibition on Survival in Patients With Metastatic Renal Cell Carcinoma and Type 2 Diabetes Mellitus Ali, Soham

22 5 p.
artikel
27 Influence of Tumor Characteristics and Time to Metastatic Disease on Oncological Outcomes in Metachronous Metastatic Prostate Cancer Patients Wenzel, Mike

22 5 p.
artikel
28 Italian Registry on Rare Urological Tumors (Meet-URO-23): The First Analysis on Collecting Duct Carcinoma of the Kidney Giudice, Giulia Claire

22 5 p.
artikel
29 Metastatic Tropism in Urothelial Carcinoma With Variant Histology: A Comprehensive NCDB Analysis Drouaud, Arthur

22 5 p.
artikel
30 Neoadjuvant Versus Adjuvant Chemotherapy in Non-Metastatic Locally-Advanced Stage Radical Cystectomy Candidates de Angelis, Mario

22 5 p.
artikel
31 New Insights of Target Therapy: Effects of Tyrosine Kinase Inhibitors on Male Gonadal Function: A Systematic Review Marino, Marta

22 5 p.
artikel
32 Objective Response Rate is a Surrogate Marker for Long-Term Overall Survival in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors Tural, Deniz

22 5 p.
artikel
33 Organ-Specific Tumor Response to Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study Minato, Akinori

22 5 p.
artikel
34 Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS—Meet-URO 26 Study Fotia, Giuseppe

22 5 p.
artikel
35 Outcomes of Intraoperative Frozen Section Examination of Surgical Resection Margins of the Penis in Penile Cancer Pang, Karl H.

22 5 p.
artikel
36 Pathological Response and Outcomes in Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Immunotherapy-Based Therapies and Undergoing Deferred Cytoreductive Nephrectomy (CN) Gunenc, Damla

22 5 p.
artikel
37 Perineural Invasion as a Risk Factor For Soft Tissue Progression in Patients With Metastatic Castration-Resistant Prostate Cancer After Abiraterone Resistance Yang, Tao

22 5 p.
artikel
38 Predicting Treatment Effects from Surrogate Endpoints in Historical Trials in First-Line Metastatic Castration-Resistant Prostate Cancer Samjoo, Imtiaz A.

22 5 p.
artikel
39 Prognostic Model and Immune Response of Clear Cell Renal Cell Carcinoma Based on Co-Expression Genes Signature Yang, Dongsheng

22 5 p.
artikel
40 Prognostic Nutritional Index (PNI) as Independent Predictor of Poor Survival in Prostate Cancer: A Systematic Review and Meta-Analysis Tobing, Edwin

22 5 p.
artikel
41 Prognostic Value of NLR, PLR, SII, and dNLR in Urothelial Bladder Cancer Following Radical Cystectomy Salari, Abolfazl

22 5 p.
artikel
42 PSA Levels and Mortality in Prostate Cancer Patients Jehle, Dietrich von Kuenssberg

22 5 p.
artikel
43 Rates of Systemic Therapy for Metastatic Bladder Cancer Are Lower in Unmarried Males and Females Vitucci, Kira

22 5 p.
artikel
44 Real-world Treatment Sequencing and Outcomes With Cabozantinib After First-line Immune Checkpoint Inhibitor-based Combination Therapy For Patients With Advanced Renal Cell Carcinoma: CARINA Study Results Nathan, Paul

22 5 p.
artikel
45 Regional Differences in Stage III Nonseminoma Germ Cell Tumor Patients Across SEER Registries Cano Garcia, Cristina

22 5 p.
artikel
46 Survival of Metastatic Urothelial Carcinoma of Urinary Bladder According to Number and Location of Visceral Metastases Di Bello, Francesco

22 5 p.
artikel
47 Surviving the Storm: Challenges of Bladder Cancer Care During the COVID-19 Pandemic Vinícius Suartz, Caio

22 5 p.
artikel
48 The Clinicopathological Characteristics and Prognosis of 55 Patients With TFE3-Rearranged Renal Cell Carcinomas Bai, Yin-Miao

22 5 p.
artikel
49 The Development and Feasibility of a Novel Electronic Patient-Reported Outcome Measures (Eproms) Questionnaire in patients with penile cancer Adegboye, Oluwatobi

22 5 p.
artikel
50 The Impact of Fibroblast Growth Factor Receptor Alterations in Clinical Outcomes of Patients With Advanced Urothelial Carcinoma: Real-World Data From a Latin American Population Souza, Vinicius Carrera

22 5 p.
artikel
51 The Incidence of Extreme Serum Prostate Specific Antigen Levels During the COVID-19 Pandemic Hird, Amanda E.

22 5 p.
artikel
52 “The Prognostic Value of Human Papillomavirus Status in Penile Cancer: Outcomes From a Norwegian Cohort Study.” Jeyaraj, Gnanaprakash

22 5 p.
artikel
53 The Prognostic Value of Human Papillomavirus Status in Penile Cancer: Outcomes From a Norwegian Cohort Study Nordanger, Ida M.

22 5 p.
artikel
54 The Use of Lurbinectedin for the Treatment of Small Cell and Neuroendocrine Carcinoma of the Prostate Meyer, Haley

22 5 p.
artikel
                             54 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland